Combined chemotherapy radiotherapy management of stage 3 Hodgkin's disease.
作者信息
Gamble J F, Fuller L M, Ibrahim E, Butler J J, Shullenberger C C
出版信息
Arch Intern Med. 1973 Mar;131(3):435-8. doi: 10.1001/archinte.131.3.435.
PMID:4688041
Abstract
摘要
相似文献
1
Combined chemotherapy radiotherapy management of stage 3 Hodgkin's disease.
Arch Intern Med. 1973 Mar;131(3):435-8. doi: 10.1001/archinte.131.3.435.
2
Splenectomy effects on chemotherapy in Hodgkin's disease.
Arch Intern Med. 1973 Mar;131(3):362-6.
3
Combination chemotherapy and survival in advanced Hodgkin's disease.
Arch Intern Med. 1973 Mar;131(3):388-90.
4
Updated Hodgkins' disease. C. Advanced disease and special problems. Advances in chemotherapy.
JAMA. 1973 Jan 8;223(2):166-8. doi: 10.1001/jama.223.2.166.
5
Status and perspectives in chemotherapy of Hodgkin's disease.霍奇金淋巴瘤化疗的现状与展望
Arch Intern Med. 1973 Mar;131(3):439-45.
6
Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
Arch Intern Med. 1973 Mar;131(3):391-5. doi: 10.1001/archinte.131.3.391.
7
Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program.
JAMA. 1973 Jan 8;223(2):168-9. doi: 10.1001/jama.223.2.168.
8
Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.放射疗法与化学疗法联合治疗霍奇金病
Ser Haematol. 1973;6(2):202-43.
9
Updated Hodgkin's disease. C. Advanced disease and special problems. Management with combination therapy.
JAMA. 1973 Jan 8;223(2):164-6. doi: 10.1001/jama.223.2.164.
10
MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
Cancer. 1973 Jul;32(1):52-60. doi: 10.1002/1097-0142(197307)32:1<52::aid-cncr2820320107>3.0.co;2-s.
Zotero 插件